Afuco™ Anti-TNFSF13B ADCC Therapeutic Antibody (Belimumab), ADCC Enhanced

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to Human BLyS. Belimumab (trade name Benlysta, previously known as LymphoStat-B) is a human monoclonal antibody that inhibits B-cell activating factor (BAFF), also known as B-lymphocyte stimulator (BLyS). B cells are responsible for part of the normal immune response, and also for the over-aggressive immune response in autoimmune diseases like systemic lupus erythematosus (SLE).
Supplier Creative Biolabs
Product # AFC-TAB-030
Pricing Inquiry
Host Human
Target TNFSF13B
Species Reactivity Human
Type ADCC enhanced antibody
Applications FC, IP, ELISA, Neut, FuncS, IF
Storage Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback